Tony Sehr

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

Katja Thomas, Tony Sehr, Undine Proschmann et al. · Journal of Neuroinflammation · 2017 · 65 citations · Full text

Life Sciences, Immunology, Neurology +17

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Tony Sehr, Undine Proschmann, Katja Thomas et al. · Journal of Neuroinflammation · 2016 · 47 citations · Full text

Life Sciences, Neurology, Pharmacology +17

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

Tjalf Ziemssen, Hayrettin Tumani, Tony Sehr et al. · Journal of Neuroinflammation · 2017 · 18 citations · Full text

Life Sciences, Neurology, Pharmacology +14

Early central vs. peripheral immunological and neurobiological effects of fingolimod—a longitudinal study

Tony Sehr, Katja Akgün, Undine Proschmann et al. · Journal of Molecular Medicine · 2019 · 15 citations

Life Sciences, Immunology, Neurobiology +9

Successful Treatment of Systemic-Sclerosis-Related Digital Ulcers with a Selective Endothelin Type A Receptor Antagonist (Sitaxentan)

Patrick Gholam, Tony Sehr, Alexander Enk et al. · Dermatology · 2009 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +10